Wellesley Pharmaceuticals Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series D

  • Latest Deal Amount
  • $10M

  • Investors
  • 4

Wellesley Pharmaceuticals General Information

Description

Developer of a pharmaceutical platform intended to treat nocturia disease of patients. The company's platform assists in treating the frequent need to urinate at night and eliminating nocturia symptoms which can be disseminated, enabling patients to sleep well at night without using the bathroom.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Corporate Office
  • 3 Valley View Drive
  • Newtown, PA 18940
  • United States
+1 (215) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Wellesley Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series D) 18-Apr-2016 $10M 000.00 0000 Completed Clinical Trials - Phase 2
3. Later Stage VC (Series C) 01-Apr-2015 00.00 00.000 0000 Completed Clinical Trials - Phase 2
2. Angel (individual) 01-Oct-2014 $550K $1.05M 000.00 Completed Clinical Trials - Phase 2
1. Angel (individual) 11-Jun-2014 $500K $500K 000.00 Completed Clinical Trials - Phase 2
To view Wellesley Pharmaceuticals’s complete valuation and funding history, request access »

Wellesley Pharmaceuticals Patents

Wellesley Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2019069991-A Pharmaceutical formulations for reducing bladder spasms and use methods thereof Pending 27-Dec-2018 0
JP-2019031556-A Pharmaceutical formulation for reducing frequency of urination and method of use thereof Pending 31-Oct-2018
US-20190374474-A1 Pharmaceutical compositions and methods for weight loss Inactive 11-Jun-2018 0000000000 0
AU-2016370313-A1 Composition for reducing frequency of urination, method of making and use thereof Inactive 18-Dec-2015 000000000
EP-3389661-A1 Composition for reducing frequency of urination, method of making and use thereof Inactive 18-Dec-2015 A61K9/209
To view Wellesley Pharmaceuticals’s complete patent history, request access »

Wellesley Pharmaceuticals Executive Team (3)

Name Title Board Seat Contact Info
David Dill Founder, Co-Chief Executive Officer, President & Board Member
Kenneth Dill Co-Chief Executive Officer, Chairman and President
You’re viewing 2 of 3 executive team members. Get the full list »

Wellesley Pharmaceuticals Board Members (7)

Name Representing Role Since
John Balian Self Board Member 000 0000
Jukka Karjalainen MD Self Board Member 000 0000
Kenneth Dill Self Co-Chief Executive Officer, Chairman and President 000 0000
Michael Myers Ph.D Self Board Member 000 0000
You’re viewing 4 of 7 board members. Get the full list »

Wellesley Pharmaceuticals Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Cliff Miller Angel (individual) Minority 000 0000 000000 0
David Shantz Angel (individual) Minority 000 0000 000000 0
Axella Bioventures Venture Capital Minority 000 0000 000000 0
Keiretsu Forum Angel Group Minority 000 0000 000000 0
To view Wellesley Pharmaceuticals’s complete investors history, request access »

Wellesley Pharmaceuticals FAQs

  • When was Wellesley Pharmaceuticals founded?

    Wellesley Pharmaceuticals was founded in 2011.

  • Who is the founder of Wellesley Pharmaceuticals?

    David Dill is the founder of Wellesley Pharmaceuticals.

  • Who is the CEO of Wellesley Pharmaceuticals?

    David Dill and Kenneth Dill are the CEOs of Wellesley Pharmaceuticals.

  • Where is Wellesley Pharmaceuticals headquartered?

    Wellesley Pharmaceuticals is headquartered in Newtown, PA.

  • What industry is Wellesley Pharmaceuticals in?

    Wellesley Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Wellesley Pharmaceuticals a private or public company?

    Wellesley Pharmaceuticals is a Private company.

  • What is the current valuation of Wellesley Pharmaceuticals?

    The current valuation of Wellesley Pharmaceuticals is 0000.

  • What is Wellesley Pharmaceuticals’s current revenue?

    The current revenue for Wellesley Pharmaceuticals is 000000.

  • How much funding has Wellesley Pharmaceuticals raised over time?

    Wellesley Pharmaceuticals has raised $12.6M.

  • Who are Wellesley Pharmaceuticals’s investors?

    Cliff Miller, David Shantz, Axella Bioventures, and Keiretsu Forum have invested in Wellesley Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »